SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-061392
Filing Date
2018-12-06
Accepted
2018-12-06 18:19:21
Documents
2
Period of Report
2018-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1648
2 EX-24 DOCUMENT attachment1.htm EX-24 2242
  Complete submission text file 0001209191-18-061392.txt   5616
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address ONE GATEWAY CENTER, SUITE 351 300 WASHINGTON STREET NEWTON MA 02458
Business Address
Jutt-Eghbali Salma (Reporting) CIK: 0001760856 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33004 | Film No.: 181221858